Literature DB >> 7833197

Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

M L Rigby1, A N Redington.   

Abstract

OBJECTIVES: The starting hypothesis was that some perimembranous ventricular septal defects can be closed safely and effectively with a Bard Rashkind double umbrella introduced through a long transvenous sheath.
DESIGN: A descriptive study of all patients who underwent attempted transcatheter umbrella closure of a perimembranous ventricular septal defect. Those patients selected for the study had symptoms of a ventricular septal defect and a perimembranous ventricular septal defect shown by transthoracic echocardiography. The morphological criteria used were a posterior perimembranous defect with a diameter of < or = 8 mm not associated with overriding of the aortic or pulmonary valve or with aortic valve prolapse. The haemodynamic criteria for inclusion in the study were a right to left ventricular systolic pressure ratio of > 0.45, a Doppler derived right ventricular systolic pressure of > 50 mm Hg, and a pulmonary to systemic flow ratio > 3:1.
SETTING: A tertiary referral centre. PATIENTS: 13 infants, children, and adolescents with a perimembranous ventricular septal defect aged 3 weeks to 16 years and weighing 1.8-46 kg.
INTERVENTIONS: A modified Rashkind ductal double umbrella was introduced through a long transvenous sheath and positioned on either side of the ventricular septal defect. Placement was guided by transoesophageal echocardiography.
RESULTS: 10 out of 13 patients underwent successful partial or complete closure of a perimembranous ventricular septal defect. There were three placement failures. Two of these were associated with a ventricular septal defect too large for the umbrella device. In a third case the umbrella was opened in the left ventricular outflow tract necessitating surgical removal and closure of the ventricular septal defect.
CONCLUSION: Transcatheter umbrella closure of a perimembranous ventricular septal defect is technically feasible and can be therapeutically successful, although the procedure is moderately difficult to perform and the mean procedure time is > 120 minutes. It is an alternative to surgery in some cases, but the overall results would not support its routine use even with the introduction of larger devices of the current design.

Entities:  

Mesh:

Year:  1994        PMID: 7833197      PMCID: PMC1025549          DOI: 10.1136/hrt.72.4.368

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  Front-loading of double-umbrella devices, a new technique for umbrella delivery for closing cardiovascular defects.

Authors:  S B Perry; J E Lock
Journal:  Am J Cardiol       Date:  1992-10-01       Impact factor: 2.778

2.  Double-umbrella closure of atrial defects. Initial clinical applications.

Authors:  J J Rome; J F Keane; S B Perry; P J Spevak; J E Lock
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

3.  Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk.

Authors:  N D Bridges; J E Lock; A R Castaneda
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  Preoperative transcatheter closure of congenital muscular ventricular septal defects.

Authors:  N D Bridges; S B Perry; J F Keane; S A Goldstein; V Mandell; J E Mayer; R A Jonas; A R Casteneda; J E Lock
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

5.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

6.  Novel uses of the Rashkind ductal umbrella in adults and children with congenital heart disease.

Authors:  A N Redington; M L Rigby
Journal:  Br Heart J       Date:  1993-01

7.  Classification of ventricular septal defects.

Authors:  B Soto; A E Becker; A J Moulaert; J T Lie; R H Anderson
Journal:  Br Heart J       Date:  1980-03

8.  Transcatheter occlusion of ventricular septal defect.

Authors:  M P O'Laughlin; C E Mullins
Journal:  Cathet Cardiovasc Diagn       Date:  1989-07

9.  Transcatheter closure of ventricular septal defects.

Authors:  J E Lock; P C Block; R G McKay; D S Baim; J F Keane
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

  9 in total
  20 in total

Review 1.  Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 2.  Catheter closure of congenital muscular ventricular septal defects.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Transcatheter closure of perimembranous ventricular septal defect: is the risk of heart block too high a price?

Authors:  Ian D Sullivan
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

4.  Transcatheter occlusion of cardiac defects.

Authors:  P S Rao; E B Sideris
Journal:  Br Heart J       Date:  1995-06

5.  Transcatheter umbrella closure of aorto-pulmonary window.

Authors:  R M Tulloh; M L Rigby
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

6.  Retrograde closure of perimembranous ventricular septal defect using muscular ventricular septal occluder: a single-center experience of a novel technique.

Authors:  Kalyanasundaram Muthusamy
Journal:  Pediatr Cardiol       Date:  2014-08-20       Impact factor: 1.655

7.  Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study.

Authors:  J Masura; W Gao; P Gavora; K Sun; A Q Zhou; S Jiang; L Ting-Liang; Y Wang
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

8.  Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.

Authors:  B D Thanopoulos; M L Rigby
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

9.  Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children.

Authors:  B D Thanopoulos; G S Tsaousis; E Karanasios; N G Eleftherakis; C Paphitis
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

10.  Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II.

Authors:  M Kanaan; P Ewert; F Berger; S Assa; S Schubert
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.